Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17021
Country/Region: South Africa
Year: 2017
Main Partner: Right to Care
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $19,350,805 Additional Pipeline Funding: $280,520

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $3,158,244
Care: TB/HIV (HVTB) $2,575,766
Care: Pediatric Care and Support (PDCS) $669,880
Health Systems Strengthening (OHSS) $0
Prevention: HIV Testing and Counseling (HVCT) $212,449
Sexual Prevention: Other Sexual Prevention (HVOP) $63,142
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,339,760
Treatment: Adult Treatment (HTXS) $10,661,684
Treatment: Pediatric Treatment (PDTX) $669,880
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD 10-14, Female, Physical and/or Emotional Violence 2018 30
GEND_GBV_DSD 10-14, Female, Sexual Violence (Post-Rape Care) 2018 20
GEND_GBV_DSD 15-19, Female, Physical and/or Emotional Violence 2018 45
GEND_GBV_DSD 15-19, Female, Sexual Violence (Post-Rape Care) 2018 60
GEND_GBV_DSD 20-24, Female, Physical and/or Emotional Violence 2018 45
GEND_GBV_DSD 20-24, Female, Sexual Violence (Post-Rape Care) 2018 41
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2018 60
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 120
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2018 121
GEND_GBV_DSD Number of people receiving post-GBV care 2018 241
HTC_TST_DSD By Test Result: Positive 2018 30,466
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 252,011
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 10-14, Female, Negative 2018 51
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 10-14, Female, Positive 2018 4
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 15-19, Female, Negative 2018 253
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 15-19, Female, Positive 2018 22
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 20-24, Female, Negative 2018 202
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 20-24, Female, Positive 2018 18
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 20-24, Male, Negative 2018 87
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 20-24, Male, Positive 2018 8
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 25-49, Male, Negative 2018 130
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: 25-49, Male, Positive 2018 11
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: Unknown Age, Female, Negative 2018 414
HTC_TST_DSD Service Delivery Point (Community) Homebased testing: Unknown Age, Female, Positive 2018 4
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2018 312
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2018 20
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 1,558
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 99
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 1,247
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 80
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 534
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 34
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 801
HTC_TST_DSD Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 51
HTC_TST_DSD Service Delivery Point (Community) Index Mod: Unknown Age, Female, Negative 2018 51
HTC_TST_DSD Service Delivery Point (Community) Index Mod: Unknown Age, Female, Positive 2018 1
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2018 367
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2018 23
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 1,835
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 117
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 1,468
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 94
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 629
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 40
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 944
HTC_TST_DSD Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 60
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 1,222
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 252
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 306
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 63
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 306
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 63
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 567
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 116
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 377
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 78
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 1,699
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 349
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 1,132
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 233
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 2,832
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 580
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 1,887
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 387
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 567
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 116
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 377
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 78
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: <1, Positive 2018 44
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2018 2,126
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2018 341
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 1
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 6
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 2
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 7
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 7
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 18
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 8
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 23
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 11
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 31
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 14
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 38
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 1
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 6
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 2
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 7
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 13
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 1
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 7
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 37
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 7
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 23
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 6
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 60
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 13
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 39
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 8
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 13
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 7
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 264
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 8
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 791
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 24
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 1,319
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 40
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 50+, Negative 2018 264
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 50+, Positive 2018 8
HTC_TST_DSD Service Delivery Point (Facility)Other PITC: <1, Negative 2018 204
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 109,379
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 14,232
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 72,938
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 9,525
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 2,751
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 378
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 2,751
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 378
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 268
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 655
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 327
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 807
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 3,415
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 469
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 2,325
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 314
HTC_TST_DSD Sum of Test Result disaggregates 2018 30,466
HTC_TST_TA By Test Result: Positive 2018 73,022
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 565,605
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 3,139
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 646
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 784
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 160
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 784
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 160
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 1,448
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 299
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 968
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 199
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 4,350
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 873
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 2,896
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 596
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 7,255
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 1,488
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 4,838
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 992
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 1,448
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 299
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 968
HTC_TST_TA Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 199
HTC_TST_TA Service Delivery Point (Facility) Other PITC: <1, Negative 2018 520
HTC_TST_TA Service Delivery Point (Facility) Other PITC: <1, Positive 2018 104
HTC_TST_TA Service Delivery Point (Facility) Pediatric : <5 Negative 2018 5,527
HTC_TST_TA Service Delivery Point (Facility) Pediatric : <5 Positive 2018 906
HTC_TST_TA Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 3
HTC_TST_TA Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 14
HTC_TST_TA Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 5
HTC_TST_TA Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 18
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 15
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 47
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 21
HTC_TST_TA Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 58
HTC_TST_TA Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 30
HTC_TST_TA Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 81
HTC_TST_TA Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 37
HTC_TST_TA Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 98
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 3
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 14
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 5
HTC_TST_TA Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 18
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 29
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 4
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 19
HTC_TST_TA Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 2
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 87
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 18
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 58
HTC_TST_TA Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 12
HTC_TST_TA Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 147
HTC_TST_TA Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 29
HTC_TST_TA Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 97
HTC_TST_TA Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 19
HTC_TST_TA Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 29
HTC_TST_TA Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 4
HTC_TST_TA Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 19
HTC_TST_TA Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 2
HTC_TST_TA Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 80
HTC_TST_TA Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 2
HTC_TST_TA Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 239
HTC_TST_TA Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 7
HTC_TST_TA Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 397
HTC_TST_TA Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 12
HTC_TST_TA Service Delivery Point (Facility) VMMC: 50+, Negative 2018 80
HTC_TST_TA Service Delivery Point (Facility) VMMC: 50+, Positive 2018 2
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 256,048
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 34,246
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 170,745
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 23,159
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 6,919
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 975
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 7,035
HTC_TST_TA Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 1,323
HTC_TST_TA Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 599
HTC_TST_TA Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 1,399
HTC_TST_TA Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 737
HTC_TST_TA Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 1,723
HTC_TST_TA Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 8,574
HTC_TST_TA Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 1,207
HTC_TST_TA Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 5,705
HTC_TST_TA Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 792
HTC_TST_TA Sum of Test Result disaggregates 2018 73,022
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2018 3,176
PMTCT_ART_DSD New on ART 2018 4,223
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 7,399
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 23,552
PMTCT_ART_TA Already on ART at beginning of current pregnancy 2018 6,063
PMTCT_ART_TA New on ART 2018 8,758
PMTCT_ART_TA Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 14,821
PMTCT_ART_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 49,596
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 7,360
PMTCT_EID_DSD Number of infants with a negative virological test result between 2 and 12 months of birth 2018 2,689
PMTCT_EID_DSD Number of infants with a negative virological test result within 2 months of birth 2018 4,405
PMTCT_EID_DSD Number of infants with a positive virological test result between 2 and 12 months of birth 2018 39
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2018 227
PMTCT_EID_TA Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 14,530
PMTCT_EID_TA Number of infants with a negative virological test result between 2 and 12 months of birth 2018 5,672
PMTCT_EID_TA Number of infants with a negative virological test result within 2 months of birth 2018 8,224
PMTCT_EID_TA Number of infants with a positive virological test result between 2 and 12 months of birth 2018 92
PMTCT_EID_TA Number of infants with a positive virological test result within 2 months of birth 2018 542
PMTCT_STAT_DSD By Age (Denominator): 10-14 2018 73
PMTCT_STAT_DSD By Age (Denominator): 20-24 2018 7,210
PMTCT_STAT_DSD By Age (Denominator): 25-49 2018 12,658
PMTCT_STAT_DSD By Age (Denominator): 50+ 2018 1
PMTCT_STAT_DSD By Age (Denominator): <15-19 2018 4,084
PMTCT_STAT_DSD By Age (Numerator): 10-14 2018 73
PMTCT_STAT_DSD By Age (Numerator): 15-19 2018 4,003
PMTCT_STAT_DSD By Age (Numerator): 20-24 2018 7,059
PMTCT_STAT_DSD By Age (Numerator): 25-49 2018 12,415
PMTCT_STAT_DSD By Age (Numerator): 50+ 2018 1
PMTCT_STAT_DSD By Number of known positives: 10-14 2018 3
PMTCT_STAT_DSD By Number of known positives: 15-19 2018 579
PMTCT_STAT_DSD By Number of known positives: 20-24 2018 1,023
PMTCT_STAT_DSD By Number of known positives: 25-49 2018 1,796
PMTCT_STAT_DSD By Number of new negative: 10-14 2018 53
PMTCT_STAT_DSD By Number of new negative: 15-19 2018 2,731
PMTCT_STAT_DSD By Number of new negative: 20-24 2018 4,823
PMTCT_STAT_DSD By Number of new negative: 25-49 2018 8,463
PMTCT_STAT_DSD By Number of new positives: 10-14 2018 4
PMTCT_STAT_DSD By Number of new positives: 15-19 2018 693
PMTCT_STAT_DSD By Number of new positives: 20-24 2018 1,227
PMTCT_STAT_DSD By Number of new positives: 25-49 2018 2,151
PMTCT_STAT_DSD By Number of new positives: 50+ 2018 6
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 23,552
PMTCT_STAT_TA By Age (Denominator): 10-14 2018 145
PMTCT_STAT_TA By Age (Denominator): 15-19 2018 8,595
PMTCT_STAT_TA By Age (Denominator): 20-24 2018 15,189
PMTCT_STAT_TA By Age (Denominator): 25-49 2018 26,684
PMTCT_STAT_TA By Age (Denominator): 50+ 2018 2
PMTCT_STAT_TA By Age (Numerator): 10-14 2018 149
PMTCT_STAT_TA By Age (Numerator): 20-24 2018 14,875
PMTCT_STAT_TA By Age (Numerator): 25-49 2018 26,142
PMTCT_STAT_TA By Age (Numerator): 50+ 2018 3
PMTCT_STAT_TA By Age (Numerator): : 15-19 2018 8,428
PMTCT_STAT_TA By known positives: 10-14 2018 4
PMTCT_STAT_TA By known positives: 15-19 2018 1,170
PMTCT_STAT_TA By known positives: 20-24 2018 2,080
PMTCT_STAT_TA By known positives: 25-49 2018 3,643
PMTCT_STAT_TA By new negatives: 10-14 2018 103
PMTCT_STAT_TA By new negatives: 15-19 2018 5,786
PMTCT_STAT_TA By new negatives: 20-24 2018 10,207
PMTCT_STAT_TA By new negatives: 25-49 2018 17,914
PMTCT_STAT_TA By new negatives: 50+ 2018 1
PMTCT_STAT_TA By new positives: 10-14 2018 8
PMTCT_STAT_TA By new positives: 15-19 2018 1,484
PMTCT_STAT_TA By new positives: 20-24 2018 2,606
PMTCT_STAT_TA By new positives: 25-49 2018 4,585
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 49,596
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 938
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,191
TB_ART_DSD Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 54
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 74
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,292
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,634
TB_ART_DSD Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 75
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 102
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 2,357
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 3,011
TB_ART_TA Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3,472
TB_ART_TA Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3,419
TB_ART_TA Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 219
TB_ART_TA Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 216
TB_ART_TA Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 4,783
TB_ART_TA Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 4,700
TB_ART_TA Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 327
TB_ART_TA Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 304
TB_ART_TA The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 8,806
TB_ART_TA The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 8,641
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2018 3,384
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2018 4,655
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2018 202
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2018 276
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2018 1,688
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2018 2,333
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2018 99
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2018 137
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 4,256
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 8,517
TB_PREV_TA By Age/Sex (Denominator): 15+, Female 2018 12,359
TB_PREV_TA By Age/Sex (Denominator): 15+, Male 2018 16,851
TB_PREV_TA By Age/Sex (Denominator): <15, Female 2018 715
TB_PREV_TA By Age/Sex (Denominator): <15, Male 2018 1,171
TB_PREV_TA By Age/Sex (Numerator): 15+, Female 2018 6,200
TB_PREV_TA By Age/Sex (Numerator): 15+, Male 2018 8,542
TB_PREV_TA By Age/Sex (Numerator): <15, Female 2018 353
TB_PREV_TA By Age/Sex (Numerator): <15, Male 2018 511
TB_PREV_TA The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 15,622
TB_PREV_TA The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 31,040
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,757
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,735
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 111
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 109
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,435
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,397
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 149
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 145
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 4,402
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2018 4,453
TB_STAT_TA Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 5,057
TB_STAT_TA Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 4,992
TB_STAT_TA Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 323
TB_STAT_TA Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 323
TB_STAT_TA Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 7,030
TB_STAT_TA Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 6,914
TB_STAT_TA Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 453
TB_STAT_TA Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 449
TB_STAT_TA Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 12,749
TB_STAT_TA Total number of registered new and relapsed TB cases, during the reporting period 2018 12,853
TX_CURR_DSD Age/Sex: 10-14 Female 2018 29
TX_CURR_DSD Age/Sex: 10-14 Male 2018 29
TX_CURR_DSD Age/Sex: 15-19 Female 2018 1,540
TX_CURR_DSD Age/Sex: 15-19 Male 2018 590
TX_CURR_DSD Age/Sex: 20-24 Female 2018 4,622
TX_CURR_DSD Age/Sex: 20-24 Male 2018 1,766
TX_CURR_DSD Age/Sex: 25-49 Female 2018 7,701
TX_CURR_DSD Age/Sex: 25-49 Male 2018 2,950
TX_CURR_DSD Age/Sex: 50+ Female 2018 1,540
TX_CURR_DSD Age/Sex: 50+ Male 2018 590
TX_CURR_DSD Age/Sex: <1 2018 20
TX_CURR_DSD Age/Sex: <1-9 2018 114
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2018 85,388
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2018 34,838
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2018 2,555
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2018 2,555
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2018 148,611
TX_CURR_DSD Sum of age/sex disaggregates 2018 2,130
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2018 120,226
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2018 5,110
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2018 125,336
TX_CURR_TA Age/Sex: 1-9 2018 460
TX_CURR_TA Age/Sex: 10-14 Female 2018 117
TX_CURR_TA Age/Sex: 10-14 Male 2018 117
TX_CURR_TA Age/Sex: 15-19 Female 2018 6,235
TX_CURR_TA Age/Sex: 15-19 Male 2018 2,389
TX_CURR_TA Age/Sex: 20-24 Female 2018 18,705
TX_CURR_TA Age/Sex: 20-24 Male 2018 7,167
TX_CURR_TA Age/Sex: 25-49 Female 2018 31,178
TX_CURR_TA Age/Sex: 25-49 Male 2018 11,938
TX_CURR_TA Age/Sex: 50+ Female 2018 6,235
TX_CURR_TA Age/Sex: 50+ Male 2018 2,387
TX_CURR_TA Age/Sex: <1 2018 80
TX_CURR_TA Aggregated Age/Sex: 15+ Female 2018 159,077
TX_CURR_TA Aggregated Age/Sex: 15+ Male 2018 63,656
TX_CURR_TA Aggregated Age/Sex: <15 Female 2018 5,114
TX_CURR_TA Aggregated Age/Sex: <15 Male 2018 5,113
TX_CURR_TA Number of adults and children receiving antiretroviral therapy (ART) 2018 320,497
TX_CURR_TA Sum of Age/Sex disaggregations 2018 8,624
TX_CURR_TA Sum of Aggregated Age/Sex 15+ 2018 222,733
TX_CURR_TA Sum of Aggregated Age/Sex <15 2018 10,227
TX_CURR_TA Sum of Aggregated Age/Sex disaggregates 2018 232,960
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2018 17,264
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2018 7,116
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2018 585
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2018 585
TX_NEW_DSD By Age/Sex: 1-9 2018 66
TX_NEW_DSD By Age/Sex: 10-14 Female 2018 16
TX_NEW_DSD By Age/Sex: 10-14 Male 2018 16
TX_NEW_DSD By Age/Sex: 15-19 Female 2018 159
TX_NEW_DSD By Age/Sex: 15-19 Male 2018 61
TX_NEW_DSD By Age/Sex: 20-24 Female 2018 476
TX_NEW_DSD By Age/Sex: 20-24 Male 2018 184
TX_NEW_DSD By Age/Sex: 25-49 Female 2018 795
TX_NEW_DSD By Age/Sex: 25-49 Male 2018 306
TX_NEW_DSD By Age/Sex: 50+ Female 2018 159
TX_NEW_DSD By Age/Sex: 50+ Male 2018 60
TX_NEW_DSD By Age/Sex: <1 2018 10
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 27,855
TX_NEW_DSD Pregnancy status 2018 6,073
TX_NEW_DSD Sum of Age/Sex disaggregates 2018 2,232
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2018 25,550
TX_NEW_TA Aggregated Grouping by Age/Sex: 15+ Female 2018 32,712
TX_NEW_TA Aggregated Grouping by Age/Sex: 15+ Male 2018 13,120
TX_NEW_TA Aggregated Grouping by Age/Sex: <15 Female 2018 1,107
TX_NEW_TA Aggregated Grouping by Age/Sex: <15 Male 2018 1,104
TX_NEW_TA By Age/Sex: 1-9 2018 266
TX_NEW_TA By Age/Sex: 10-14 Female 2018 66
TX_NEW_TA By Age/Sex: 10-14 Male 2018 66
TX_NEW_TA By Age/Sex: 15-19 Female 2018 643
TX_NEW_TA By Age/Sex: 15-19 Male 2018 250
TX_NEW_TA By Age/Sex: 20-24 Female 2018 1,927
TX_NEW_TA By Age/Sex: 20-24 Male 2018 745
TX_NEW_TA By Age/Sex: 25-49 Female 2018 3,210
TX_NEW_TA By Age/Sex: 25-49 Male 2018 1,238
TX_NEW_TA By Age/Sex: 50+ Female 2018 643
TX_NEW_TA By Age/Sex: 50+ Male 2018 249
TX_NEW_TA By Age/Sex: <1 2018 44
TX_NEW_TA Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 57,393
TX_NEW_TA Pregnancy status 2018 12,859
TX_NEW_TA Sum of Age/Sex disaggregates 2018 9,037
TX_NEW_TA Sum of Aggregated Age/Sex disaggregates 2018 48,043
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 92,770
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 37,432
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,418
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,418
TX_PVLS_DSD Denominator: Indication: Routine 2018 135,039
TX_PVLS_DSD Denominator: Preg/BF by Indication: Pregnant Routine 2018 28,152
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 135,039
TX_PVLS_DSD Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 121,534
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 83,503
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 33,689
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,166
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,176
TX_PVLS_DSD Numerator: Indication: Routine 2018 121,534
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Routine 2018 26,473
TX_PVLS_TA Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 200,303
TX_PVLS_TA Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 78,908
TX_PVLS_TA Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 5,539
TX_PVLS_TA Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 5,146
TX_PVLS_TA Denominator: Indication: Routine 2018 289,940
TX_PVLS_TA Denominator: Preg/BF by Indication: Pregnant Routine 2018 63,099
TX_PVLS_TA Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 289,941
TX_PVLS_TA Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 260,947
TX_PVLS_TA Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 175,058
TX_PVLS_TA Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 68,969
TX_PVLS_TA Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 10,034
TX_PVLS_TA Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 6,485
TX_PVLS_TA Numerator: Indication: Routine 2018 260,947
TX_PVLS_TA Numerator: Preg/BF by Indication: Pregnant Routine 2018 59,769
TX_PVLS_TA Unknown Age, Routine, Female 2018 200
TX_PVLS_TA Unknown Age, Routine, Female 2018 22
TX_PVLS_TA Unknown Age, Routine, Male 2018 200
TX_PVLS_TA Unknown Age, Routine, Male 2018 22
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 21,772
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 19,189
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 8,650
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 7,627
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 495
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 427
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 495
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 427
TX_RET_DSD Denominator by Status: Pregnant 2018 7,093
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 27,674
TX_RET_DSD Numerator by Status: Pregnant 2018 6,244
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 31,409
TX_RET_TA Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 50,283
TX_RET_TA Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 46,076
TX_RET_TA Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 19,639
TX_RET_TA Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 17,739
TX_RET_TA Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,055
TX_RET_TA Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 951
TX_RET_TA Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,052
TX_RET_TA Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 952
TX_RET_TA Denominator by Status: Pregnant 2018 16,828
TX_RET_TA Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 65,018
TX_RET_TA Numerator by Status: Pregnant 2018 15,187
TX_RET_TA Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 72,041
Cross Cutting Budget Categories and Known Amounts Total: $1,157,421
Motor Vehicles: Leased $87,000
Human Resources for Health $1,070,421